SCHEMBL22404062

SCHEMBL22404062

c1ccc(-c2c(-c3ccccc3)n(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)c3c2ccc2c(-c4ccccc4)c(-c4ccccc4)n(-c4ccc(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)cc4)c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ KMT2A Q03164 3/20 0.42
▸ IL1R1 P14778 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ PTPN1 P18031 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.34
▸ AGTR1 P30556 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ MAPK8 P45983 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ MDM2 Q00987 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17016100 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL10021243 0.91 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016106 0.91 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL3861644 0.91 L3MBTL1 (0.57) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL9886117 0.91 L3MBTL1 (0.57) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016065 0.90 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016104 0.90 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016107 0.90 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016048 0.88 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL17016045 0.88 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AIL1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780846-B2 Compound, organic electroluminescent device including the same and electronic apparatus WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-10-10 — — US disclosed
US-11780846-B2 Compound, organic electroluminescent device including the same and electronic apparatus WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-10-10 — — US disclosed
US-20200283448-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME AND ELECTRONIC APPARATUS WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283448-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME AND ELECTRONIC APPARATUS GJB2, SLC7A5, GJA1 L3MBTL1 541/4885KDM4E 2146/4885ATM 2235/4885
US-11780846-B2 Compound, organic electroluminescent device including the same and electronic apparatus GJB2, SLC7A5, GJA1 L3MBTL1 541/4885KDM4E 2146/4885ATM 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback